Pharmacotherapy for cataplexy - 23/08/11
Doi : 10.1016/j.smrv.2004.01.004
William C. Houghton a, ⁎ 
, Thomas E. Scammell b, 1 , Michael Thorpy c, 2
, Thomas E. Scammell b, 1 , Michael Thorpy c, 2 a Orphan Medical, Inc., Medical Affairs, 13911 Ridgedale Drive, Suite 250, Minnetonka, MN 55305, USA
b Harvard Institutes of Medicine, Room 821, Beth Israel Deaconess Medical Center, 77 Ave. Louis Pasteur, Boston, MA 02115, USA
c Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA
Corresponding author. Tel.: +1-952-513-6900; fax: +1-952-541-9209Abstract |
A variety of medications representing several major drug classes improve cataplexy in patients with narcolepsy. These include aminergic reuptake inhibitors such as venlafaxine and clomipramine as well as sodium oxybate. This review is intended to familiarize readers with the safety and efficacy of these medications, thus enabling clinicians to optimize their management of cataplexy.
Le texte complet de cet article est disponible en PDF.Keywords : Narcolepsy, Cataplexy, Pharmacotherapy, Anticataplectics, Review
Plan
 | Dr. Houghton is an employee of Orphan Medical Inc, manufacturers of sodium oxybate. Dr. Scammell has received honoraria and grant support from Orphan Medical Inc. Dr Thorpy is on the Speakers Bureau for Orphan Medical Inc and Cephalon |
© 2004
Elsevier Ltd. Tous droits réservés.
Vol 8 - N° 5
P. 355-366 - octobre 2004 Retour au numéro
Article précédent
- Pharmacotherapy for excessive daytime sleepiness
- Dev Banerjee, Michael V. Vitiello, Ronald R. Grunstein
- GHRH and sleep
- Ferenc Obal, James M. Krueger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?